Issue navigation
Volume 72, Issue 1, January 2017
Review
Role of cephalosporins in the era of Clostridium difficile infection
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 1–18, https://doi.org/10.1093/jac/dkw385
For debate
Less-drug regimen including atazanavir in maintenance treatment of HIV infection: how, who, when, why?
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 19–28, https://doi.org/10.1093/jac/dkw368
Systematic review
Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 29–39, https://doi.org/10.1093/jac/dkw377
Original research
Genomic analysis of 495 vancomycin-resistant Enterococcus faecium reveals broad dissemination of a vanA plasmid in more than 19 clones from Copenhagen, Denmark
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 40–47, https://doi.org/10.1093/jac/dkw360
Long-term clonal dynamics of Enterococcus faecium strains causing bloodstream infections (1995–2015) in Spain
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 48–55, https://doi.org/10.1093/jac/dkw366
In vitro activity of ceftaroline against clinical Staphylococcus aureus isolates collected during a national survey conducted in Belgian hospitals
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 56–59, https://doi.org/10.1093/jac/dkw380
Report of mecC-carrying MRSA in domestic swine
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 60–63, https://doi.org/10.1093/jac/dkw389
A new mosaic integrative and conjugative element from Streptococcus agalactiae carrying resistance genes for chloramphenicol (catQ) and macrolides [mef(I) and erm(TR)]
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 64–67, https://doi.org/10.1093/jac/dkw367
Fosfomycin resistance in Acinetobacter baumannii is mediated by efflux through a major facilitator superfamily (MFS) transporter—AbaF
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 68–74, https://doi.org/10.1093/jac/dkw382
Ciprofloxacin selects for RNA polymerase mutations with pleiotropic antibiotic resistance effects
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 75–84, https://doi.org/10.1093/jac/dkw364
Low biological cost of carbapenemase-encoding plasmids following transfer from Klebsiella pneumoniae to Escherichia coli
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 85–89, https://doi.org/10.1093/jac/dkw350
Occurrence and characterization of blaNDM-5-positive Klebsiella pneumoniae isolates from dairy cows in Jiangsu, China
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 90–94, https://doi.org/10.1093/jac/dkw357
Emergence of meningococci with reduced susceptibility to third-generation cephalosporins
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 95–98, https://doi.org/10.1093/jac/dkw400
IncN ST7 epidemic plasmid carrying blaIMP-4 in Enterobacteriaceae isolates with epidemiological links to multiple geographical areas in China
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 99–103, https://doi.org/10.1093/jac/dkw353
Identification of bacterial pathogens and antimicrobial resistance directly from clinical urines by nanopore-based metagenomic sequencing
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 104–114, https://doi.org/10.1093/jac/dkw397
Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 115–127, https://doi.org/10.1093/jac/dkw381
Short- and long-term effects of oral vancomycin on the human intestinal microbiota
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 128–136, https://doi.org/10.1093/jac/dkw383
Antimicrobial activity of antisense peptide–peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 137–144, https://doi.org/10.1093/jac/dkw384
Antimicrobial resistance in Shiga toxin-producing Escherichia coli serogroups O157 and O26 isolated from human cases of diarrhoeal disease in England, 2015
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 145–152, https://doi.org/10.1093/jac/dkw371
High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 153–165, https://doi.org/10.1093/jac/dkw355
Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008–14: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 166–171, https://doi.org/10.1093/jac/dkw398
Impact of bacterial load on pharmacodynamics and susceptibility breakpoints for tigecycline and Klebsiella pneumoniae
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 172–180, https://doi.org/10.1093/jac/dkw354
Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilation
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 181–189, https://doi.org/10.1093/jac/dkw352
Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African children
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 190–199, https://doi.org/10.1093/jac/dkw388
Impact of efavirenz pharmacokinetics and pharmacogenomics on neuropsychological performance in older HIV-infected patients
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 200–204, https://doi.org/10.1093/jac/dkw403
Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 205–209, https://doi.org/10.1093/jac/dkw376
HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 210–219, https://doi.org/10.1093/jac/dkw358
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 220–226, https://doi.org/10.1093/jac/dkw348
Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 227–234, https://doi.org/10.1093/jac/dkw404
Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 235–239, https://doi.org/10.1093/jac/dkw375
Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 240–245, https://doi.org/10.1093/jac/dkw369
Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 246–253, https://doi.org/10.1093/jac/dkw379
Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysis
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 254–260, https://doi.org/10.1093/jac/dkw351
Voriconazole metabolism is influenced by severe inflammation: a prospective study
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 261–267, https://doi.org/10.1093/jac/dkw349
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 268–272, https://doi.org/10.1093/jac/dkw374
High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 273–280, https://doi.org/10.1093/jac/dkw372
Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 281–289, https://doi.org/10.1093/jac/dkw399
Evaluation of empirical treatment for blood culture-negative endocarditis
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 290–298, https://doi.org/10.1093/jac/dkw362
Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 299–304, https://doi.org/10.1093/jac/dkw402
Antibiotic prescriptions for suspected respiratory tract infection in primary care in South America
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 305–310, https://doi.org/10.1093/jac/dkw370
Patient and public understanding and knowledge of antimicrobial resistance and stewardship in a UK hospital: should public campaigns change focus?
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 311–314, https://doi.org/10.1093/jac/dkw387
Research letters
ST147 NDM-1-producing Klebsiella pneumoniae spread in two Tunisian hospitals
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 315–316, https://doi.org/10.1093/jac/dkw401
Isolation of seven distinct carbapenemase-producing Gram-negative organisms from a single patient
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 317–319, https://doi.org/10.1093/jac/dkw378
Pharmacokinetics of colistin methanesulfonate (CMS) in burn patients
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 319–321, https://doi.org/10.1093/jac/dkw361
